Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 CorMedixExicureBioventixIMVEnochian Biosciences
SymbolNYSEAMERICAN:CRMDOTCMKTS:XCURLON:BVXPTSE:IMVOTCMKTS:ENOB
Price Information
Current Price$8.25$2.62GBX 3,895C$4.00$5.57
52 Week RangeBuyBuyN/ABuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyN/A
Consensus Price Target$22.00$5.00GBX 3,700C$10.50N/A
% Upside from Price Target166.67% upside90.84% upside-5.01% downside162.50% upsideN/A
Trade Information
Market Cap$191.55 million$189.99 million£200.31 millionC$203.97 million$217.61 million
BetaN/AN/AN/AN/AN/A
Average Volume459,98543,2985,50543,29249,061
Sales & Book Value
Annual RevenueN/AN/A£8.82 millionC$51,000.00N/A
Price / SalesN/AN/A22.713,969.57N/A
CashflowN/AN/AGBX 106.20 per shareC$0.53 per shareN/A
Price / CashN/AN/A36.687.58N/A
Book ValueN/AN/AGBX 178.30 per shareC$0.42 per shareN/A
Price / BookN/AN/A0.229.59N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AGBX 106.80C($0.53)N/A
Trailing P/E Ratio0.000.0036.47N/A0.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AGBX 0.66N/AN/A
Dividend YieldN/AN/A0.02%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A0.62%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A44.63%N/A
Current RatioN/AN/A11.39%5.74%N/A
Quick RatioN/AN/A11.06%5.01%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees22271251N/A
Shares Outstanding23.83 million76.00 million5.14 million50.61 million38.79 million
Next Earnings Date11/13/2019 (Estimated)N/AN/A11/1/2019 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
 CorMedixExicureBioventixIMVEnochian Biosciences

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel